Childhood asthma, response to oral prophylaxis

ABSTRACT

The value and efficacy of ketotifen as a prophylactic drug for childhood asthma was assessed for 1 year in 45 children. Sixty seven percent showed good response, 15.5% moderate and 17.7% poor response to ketotifen therapy. The side effects [sedation, dizziness, headache] were seen in 20% children which resolved without interruption of therapy. Ketotifen appeared to be an effective and safe oral prophylactic drug for childhood asthma